{"id":57997,"date":"2024-02-27T18:11:23","date_gmt":"2024-02-27T18:11:23","guid":{"rendered":"https:\/\/medsname.com\/lametec-100-dt\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"lametec-100-dt","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/lametec-100-dt\/","title":{"rendered":"Lametec-100 DT"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Lametec-100 DT?<\/h3>\n<p style=\"margin:0;\"><strong>Lametec-100 DT<\/strong> \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5 \u03c3\u03c4\u03cc\u03bc\u03b1\u03c4\u03bf\u03c2 <strong>dispersible tablet<\/strong> (can be taken with water or dispersed in water) containing <strong>lamotrigine<\/strong> (100 mg) &mdash; a broad-spectrum anticonvulsant and mood stabiliser. Used for: <strong>partial and generalised tonic-clonic seizures<\/strong>, <strong>Lennox-Gastaut syndrome<\/strong>, \u03ba\u03b1\u03b9 <strong>maintenance therapy of bipolar I disorder<\/strong> (preventing depressive episodes). Adult dosing requires <strong>slow titration over 6 weeks<\/strong> &mdash; rapid escalation is the single biggest cause of severe rash and Stevens-Johnson syndrome. Standard maintenance: <strong>200&ndash;400 mg\/day<\/strong> in 1&ndash;2 doses. Half this dose if combined with valproate; double if combined with carbamazepine\/phenytoin. Take with or without food. Common side effects: rash, headache, dizziness, double vision. <strong>\u0394\u03b9\u03b1\u03ba\u03bf\u03c0\u03ae \u03ac\u03bc\u03b5\u03c3\u03b1<\/strong> for any new rash &mdash; SJS\/TEN risk highest in the first 8 weeks. One of the few anticonvulsants with relatively low fetal risk in pregnancy.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>\u0391\u03c5\u03c4\u03cc \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03c4\u03b5 \u03bc\u03b5 \u03c4\u03b7\u03bd MedsBase:<\/strong> \u03a0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae\u03c2 WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 <a href=\"https:\/\/medsbase.com\/el\/reviews\/\">\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>\u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n<h2 class=\"wp-block-heading\">What Is Lametec-100 DT?<\/h2>\n<p>Lametec-100 DT is an oral lamotrigine DT (dispersible tablet) available in 100 mg strengths. Lamotrigine is a phenyltriazine anticonvulsant that has been a first-line agent for <strong>focal epilepsy<\/strong>, <strong>generalised tonic-clonic seizures<\/strong> \u03ba\u03b1\u03b9 <strong>bipolar I maintenance<\/strong> since the late 1990s. It is on the WHO Model List of Essential Medicines.<\/p>\n<p>The DT (dispersible tablet) formulation can be swallowed whole, chewed, or dispersed in a small volume of water before swallowing &mdash; useful for patients who have difficulty swallowing tablets and for paediatric dosing.<\/p>\n<p>Lametec-100 DT is supplied by a WHO-GMP certified manufacturer and is bioequivalent to originator-brand lamotrigine (Lamictal&reg;).<\/p>\n<h2 class=\"wp-block-heading\">How Does Lametec-100 DT Work?<\/h2>\n<p>Lamotrigine has multiple complementary mechanisms:<\/p>\n<ul>\n<li><strong>Voltage-gated sodium channel blockade<\/strong> in a use-dependent manner &mdash; the primary anticonvulsant mechanism. It preferentially silences hyperactive neurons without affecting normal firing.<\/li>\n<li><strong>Reduction of glutamate release<\/strong> at presynaptic terminals &mdash; contributes to both seizure control and mood stabilisation.<\/li>\n<li><strong>Modest inhibition of high-voltage-activated calcium channels<\/strong> &mdash; complementary to the sodium-channel effect.<\/li>\n<\/ul>\n<p>This mechanism profile makes lamotrigine effective against <strong>focal seizures<\/strong>, <strong>generalised tonic-clonic seizures<\/strong> \u03ba\u03b1\u03b9 <strong>bipolar depression<\/strong> (the only mood-stabilising anticonvulsant licensed specifically for bipolar maintenance to prevent <em>depression<\/em>, not mania). It is generally <em>\u03b4\u03b5\u03bd<\/em> used for myoclonic seizures, where it can occasionally worsen seizure frequency.<\/p>\n<h2 class=\"wp-block-heading\">\u03a7\u03c1\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>Partial (focal) seizures with or without secondary generalisation<\/strong> &mdash; first-line monotherapy in adults and adolescents<\/li>\n<li><strong>Primary generalised tonic-clonic seizures<\/strong> &mdash; first-line, particularly in women of childbearing potential (alternative to valproate)<\/li>\n<li><strong>Lennox-Gastaut syndrome<\/strong> &mdash; adjunctive therapy for the drop attacks and atypical absences<\/li>\n<li><strong>Bipolar I disorder &mdash; maintenance therapy<\/strong> for prevention of mood episodes, particularly depressive episodes (FDA-approved). Not first-line for acute mania.<\/li>\n<li><strong>\u0395\u03ba\u03c4\u03cc\u03c2 \u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03c9\u03bd:<\/strong> bipolar II depression, treatment-resistant unipolar depression (adjunct), borderline personality disorder, peripheral neuropathy<\/li>\n<\/ul>\n<p>Lametec-100 DT is <strong>\u03b4\u03b5\u03bd<\/strong> first-line for: acute mania (use valproate or atypical antipsychotic); myoclonic seizures (can worsen them); status epilepticus (no IV form, slow onset).<\/p>\n<h2 class=\"wp-block-heading\">Lametec-100 DT Dosage and How to Take<\/h2>\n<p>Lametec-100 DT strengths: <strong>100 mg<\/strong>.<\/p>\n<p>Lamotrigine titration is <strong>indication- and co-medication-dependent<\/strong> and must always be slow. The titration schedule is the single biggest factor in avoiding severe rash.<\/p>\n<p><strong>Adult monotherapy or add-on without enzyme-inducers\/valproate (epilepsy):<\/strong><\/p>\n<ul>\n<li>Weeks 1&ndash;2: 25 mg once daily<\/li>\n<li>Weeks 3&ndash;4: 50 mg once daily<\/li>\n<li>Week 5: 100 mg once daily (or 50 mg twice daily)<\/li>\n<li>Week 6+: increase by 50&ndash;100 mg every 1&ndash;2 weeks. Maintenance 100&ndash;400 mg\/day in 1&ndash;2 doses.<\/li>\n<\/ul>\n<p><strong>Add-on to valproate (which doubles lamotrigine levels):<\/strong><\/p>\n<ul>\n<li>Weeks 1&ndash;2: 25 mg every other day<\/li>\n<li>Weeks 3&ndash;4: 25 mg once daily<\/li>\n<li>Week 5: 50 mg once daily; titrate slowly to 100&ndash;200 mg\/day total<\/li>\n<\/ul>\n<p><strong>Add-on to enzyme inducers (carbamazepine, phenytoin, phenobarbital, primidone) without valproate:<\/strong><\/p>\n<ul>\n<li>Weeks 1&ndash;2: 50 mg once daily<\/li>\n<li>Weeks 3&ndash;4: 100 mg\/day in 2 doses<\/li>\n<li>Week 5+: increase by 100 mg\/week. Maintenance 200&ndash;700 mg\/day in 2 doses.<\/li>\n<\/ul>\n<p><strong>Bipolar I maintenance:<\/strong> Same monotherapy schedule, target 200 mg\/day (or 100 mg if on valproate, 400 mg if on inducers).<\/p>\n<h3 class=\"wp-block-heading\">How to Take Lametec-100 DT Properly<\/h3>\n<ol>\n<li><strong>Follow the titration schedule exactly.<\/strong> Skipping a step or escalating faster sharply increases rash risk. There is no clinical benefit to faster titration.<\/li>\n<li><strong>With or without food.<\/strong> Food does not significantly affect absorption. If GI upset occurs, take with food.<\/li>\n<li><strong>If you miss &gt;5 consecutive days, you must restart the titration from week 1.<\/strong> Lamotrigine tolerance to rash is lost rapidly. Do not resume at the previous dose after a treatment break.<\/li>\n<li><strong>Twice-daily dosing<\/strong> at maintenance for most patients (half-life 24&ndash;30 hours, but less if on enzyme inducers). Once-daily dosing is fine for the OD\/extended-release form.<\/li>\n<li><strong>Stop the drug for any new rash<\/strong> in the first 8 weeks. Most lamotrigine rashes are benign morbilliform eruptions, but Stevens-Johnson syndrome and TEN are not distinguishable in the first 24&ndash;48 hours. The threshold to stop is very low.<\/li>\n<li><strong>Never stop abruptly<\/strong> for epilepsy &mdash; rebound seizures and status epilepticus are possible. Taper over 2 weeks unless a serious adverse reaction (rash, anaphylaxis) requires immediate cessation.<\/li>\n<li><strong>Combined oral contraceptives can halve lamotrigine levels.<\/strong> Tell your prescriber if starting or stopping the pill &mdash; the dose may need to be increased on the pill or reduced in the pill-free week.<\/li>\n<li><strong>\u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7 \u03ba\u03b1\u03b9 \u03b8\u03b7\u03bb\u03b1\u03c3\u03bc\u03cc\u03c2:<\/strong> lamotrigine is among the lower-risk anticonvulsants for fetal exposure. Levels drop dramatically in pregnancy and rise again post-partum &mdash; therapeutic-drug-monitoring in specialist clinics is recommended.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Lametec-100 DT<\/h2>\n<p><strong>Common (often dose-related, may settle):<\/strong><\/p>\n<ul>\n<li>\u039a\u03b5\u03c6\u03b1\u03bb\u03b1\u03bb\u03b3\u03af\u03b1<\/li>\n<li>\u0396\u03ac\u03bb\u03b7<\/li>\n<li>\u039d\u03b1\u03c5\u03c4\u03af\u03b1<\/li>\n<li>Diplopia (double vision)<\/li>\n<li>Drowsiness or insomnia (paradoxical &mdash; insomnia in some patients, sedation in others)<\/li>\n<li>Tremor<\/li>\n<li>Ataxia &mdash; usually with rapid titration or at high doses<\/li>\n<li>Mild morbilliform rash (5&ndash;10% of patients on slow titration)<\/li>\n<\/ul>\n<p><strong>\u039b\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03c3\u03c5\u03c7\u03bd\u03ac \u03b1\u03bb\u03bb\u03ac \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ac:<\/strong><\/p>\n<ul>\n<li>Mood activation, irritability, restlessness<\/li>\n<li>Aseptic meningitis (very rare)<\/li>\n<li>Movement disorders &mdash; tics, dystonia (rare)<\/li>\n<li>\u0391\u03cb\u03c0\u03bd\u03af\u03b1<\/li>\n<li>Worsening of myoclonic seizures in some genetic generalised epilepsies<\/li>\n<\/ul>\n<p><strong>Rare but seek emergency care:<\/strong><\/p>\n<ul>\n<li><strong>Stevens-Johnson syndrome and toxic epidermal necrolysis (TEN)<\/strong> &mdash; risk is highest in the first 8 weeks, increased by rapid titration and concurrent valproate. Approximately 1 in 1,000 adults; higher in children. Stop the drug at the first sign of any rash, mucosal involvement, or systemic illness with fever.<\/li>\n<li><strong>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)<\/strong> &mdash; fever, lymphadenopathy, hepatitis, eosinophilia. Stop immediately.<\/li>\n<li><strong>Haemophagocytic lymphohistiocytosis (HLH)<\/strong> &mdash; very rare, life-threatening immune activation. FDA warning issued 2018.<\/li>\n<li><strong>Serious cardiac arrhythmias<\/strong> &mdash; Brugada-like ECG changes have been reported in patients with structural heart disease (FDA warning 2021). Caution with pre-existing heart disease and Brugada syndrome.<\/li>\n<li>Suicidal ideation &mdash; class warning for all anticonvulsants.<\/li>\n<li>Anaphylaxis<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a0\u03c1\u03bf\u03b5\u03b9\u03b4\u03bf\u03c0\u03bf\u03b9\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03a0\u03c1\u03bf\u03c6\u03c5\u03bb\u03ac\u03be\u03b5\u03b9\u03c2 \u2014 \u039a\u03a1\u0399\u03a3\u0399\u039c\u039f<\/h2>\n<ul>\n<li><strong>Severe skin reactions (SJS\/TEN\/DRESS)<\/strong> &mdash; lamotrigine carries a black-box warning. Risk factors: rapid titration, concurrent valproate, age &lt;16, prior anticonvulsant rash. Stop for any rash and seek medical assessment within hours, not days.<\/li>\n<li><strong>Drug interactions matter more than for most anticonvulsants.<\/strong> Valproate doubles lamotrigine; carbamazepine\/phenytoin\/phenobarbital\/primidone halve it; oestrogen-containing contraceptives roughly halve it. Dosing schedules differ for each scenario.<\/li>\n<li><strong>\u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7:<\/strong> lamotrigine is one of the safer anticonvulsants in pregnancy (registry data show no clear increase in major malformations at typical doses). However lamotrigine clearance increases markedly in pregnancy; breakthrough seizures are common if the dose is not adjusted. Specialist follow-up is essential.<\/li>\n<li><strong>Cardiac warning (FDA 2021):<\/strong> caution in patients with structural heart disease, conduction system disease, or Brugada syndrome. Baseline ECG is reasonable in older adults with cardiac history.<\/li>\n<li><strong>Aseptic meningitis<\/strong> &mdash; rare but described. Headache, neck stiffness, fever after starting or after dose increase warrants assessment.<\/li>\n<li><strong>Suicidality<\/strong> &mdash; class warning. Tell a clinician for any new mood change, self-harm thought or behaviour change.<\/li>\n<li><strong>Treatment break of &gt;5 days<\/strong> &mdash; restart titration from week 1 to avoid losing rash tolerance.<\/li>\n<li><strong>Driving:<\/strong> avoid until stable on dose; double vision and dizziness can impair driving in the titration phase.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindications &mdash; Who Should NOT Take Lametec-100 DT<\/h2>\n<ul>\n<li>Known hypersensitivity to lamotrigine or any tablet excipient<\/li>\n<li>Prior severe skin reaction to any anticonvulsant<\/li>\n<li>Severe hepatic impairment (Child-Pugh C) without dose adjustment and specialist monitoring<\/li>\n<li>History of Stevens-Johnson syndrome to any drug (relative contraindication, specialist input required)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u03a3\u03c5\u03bd\u03b4\u03c5\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u0391\u03c0\u03bf\u03c4\u03ad\u03bb\u03b5\u03c3\u03bc\u03b1<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u03a4\u03b9 \u03bd\u03b1 \u03ba\u03ac\u03bd\u03b5\u03c4\u03b5<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sodium valproate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Doubles lamotrigine levels &mdash; sharply increases SJS\/TEN risk<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Halve the lamotrigine starter dose; very slow titration. Specialist supervision.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Carbamazepine, phenytoin, phenobarbital, primidone<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Halve lamotrigine levels (enzyme induction)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Use the higher titration schedule (50 mg starter, faster up-titration, higher maintenance 200&ndash;700 mg\/day).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Oestrogen-containing contraceptives<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduce lamotrigine levels by ~50%<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor seizure control; may need higher dose on pill, lower dose in pill-free week. Progestogen-only contraceptives do not significantly affect lamotrigine.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Clearance increases 2&ndash;3 fold by third trimester<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Specialist follow-up; therapeutic drug monitoring; dose increase often needed; reduce post-partum to avoid toxicity.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u03a1\u03b9\u03c6\u03b1\u03bc\u03c0\u03b9\u03ba\u03af\u03bd\u03b7<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduces lamotrigine levels (enzyme induction)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Increase dose under specialist guidance.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Lopinavir\/ritonavir, atazanavir\/ritonavir<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduce lamotrigine levels<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor levels; dose increase often needed.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sertraline (high doses)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">May modestly raise lamotrigine levels<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Usually clinically insignificant; observe for side effects after starting.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u0391\u03bb\u03ba\u03bf\u03cc\u03bb<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Additive CNS depression<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Limit alcohol entirely on Lametec-100 DT.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">\u039f\u03b4\u03b7\u03b3\u03af\u03b5\u03c2 \u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7\u03c2<\/h2>\n<ul>\n<li>\u03a6\u03c5\u03bb\u03ac\u03be\u03c4\u03b5 \u03c3\u03b5 \u03b8\u03b5\u03c1\u03bc\u03bf\u03ba\u03c1\u03b1\u03c3\u03af\u03b1 \u03b4\u03c9\u03bc\u03b1\u03c4\u03af\u03bf\u03c5, <strong>15&ndash;30&deg;C<\/strong>. Protect from light and moisture.<\/li>\n<li>Keep tablets in the original blister pack until use.<\/li>\n<li>Do not store in the bathroom.<\/li>\n<li>Keep out of reach of children &mdash; lamotrigine overdose causes seizures, coma and arrhythmia.<\/li>\n<li>Do not use after the expiry date.<\/li>\n<li>Return unused tablets to a pharmacy for proper disposal.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2 \u039b\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03bf MedsBase<\/h2>\n<p>Other medications stocked for related conditions:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/neurological-conditions-and-epilepsy\/\">Browse all neurological &amp; epilepsy medications<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/anti-migraine\/\">Browse anti-migraine medications<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/mental-health-and-psychiatric-medications\/\">Browse mental health &amp; psychiatric medications<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3 class=\"wp-block-heading\">Why does Lametec-100 DT take 6 weeks to titrate up?<\/h3>\n<p>The slow titration is <strong>specifically designed to avoid Stevens-Johnson syndrome and toxic epidermal necrolysis<\/strong>. Studies in the 1990s showed that the rash incidence is directly proportional to the speed of titration and the starting dose. The 6-week schedule reduces the rate of severe rash from ~5% to under 0.1% in adults. There is no clinical benefit from faster escalation; it only increases risk.<\/p>\n<h3 class=\"wp-block-heading\">What if I get a rash on Lametec-100 DT?<\/h3>\n<p><strong>Stop the drug and seek same-day medical assessment.<\/strong> Most lamotrigine rashes are benign maculopapular eruptions that resolve on stopping, but Stevens-Johnson syndrome cannot be reliably distinguished from a benign rash in the first 24&ndash;48 hours. Red flags that require <em>emergency<\/em> care: mucous-membrane involvement (mouth, eyes, genitals), blistering, peeling, fever, malaise. The threshold to stop Lametec-100 DT for any rash is intentionally very low.<\/p>\n<h3 class=\"wp-block-heading\">Why does the dose differ if I am on valproate or carbamazepine?<\/h3>\n<p>Other anticonvulsants change lamotrigine clearance dramatically. <strong>Valproate inhibits glucuronidation<\/strong> and roughly doubles lamotrigine levels &mdash; so you need half the usual dose, and the rash risk is sharply increased without slow titration. <strong>Carbamazepine, phenytoin, phenobarbital and primidone induce glucuronidation<\/strong> and roughly halve lamotrigine levels &mdash; so you need approximately double the usual dose. Combined oral contraceptives also halve lamotrigine levels.<\/p>\n<h3 class=\"wp-block-heading\">Is Lametec-100 DT safe in pregnancy?<\/h3>\n<p><strong>Lamotrigine is one of the safer anticonvulsants in pregnancy<\/strong>. Pregnancy registries (UK, North American) have not shown a clear increase in major congenital malformations at typical doses (&lt;200 mg\/day), particularly compared with valproate or topiramate. However, lamotrigine clearance increases substantially in pregnancy &mdash; sometimes by 200&ndash;300% by the third trimester &mdash; and breakthrough seizures are common if the dose is not adjusted. Specialist obstetric\/neurology follow-up with therapeutic drug monitoring is essential, and the dose must be reduced quickly post-partum to avoid toxicity.<\/p>\n<h3 class=\"wp-block-heading\">Can Lametec-100 DT treat depression?<\/h3>\n<p><strong>For bipolar depression, yes &mdash; lamotrigine is FDA-approved for maintenance therapy of bipolar I disorder, particularly preventing depressive episodes<\/strong>. For unipolar depression it is sometimes used as an augmentation agent in treatment-resistant cases but is not first-line. Effect on bipolar depression takes 6&ndash;12 weeks to develop fully because of the slow titration. It is <em>\u03b4\u03b5\u03bd<\/em> effective for acute mania.<\/p>\n<h3 class=\"wp-block-heading\">What happens if I miss several days of Lametec-100 DT?<\/h3>\n<p>If you miss more than <strong>5 consecutive days<\/strong>, you lose the tolerance that the slow titration built up &mdash; the rash risk on resumption at the previous dose is unacceptably high. <strong>You must restart the titration from week 1<\/strong> if you have a treatment break of &gt;5 days, regardless of how long you were stable before the break. This is the same rule as initial titration.<\/p>\n<h3 class=\"wp-block-heading\">Will Lametec-100 DT cause weight gain?<\/h3>\n<p><strong>Generally weight-neutral.<\/strong> Lamotrigine is one of the few anticonvulsants and mood stabilisers that does <em>\u03b4\u03b5\u03bd<\/em> typically cause weight gain &mdash; in contrast to valproate, gabapentin, pregabalin, olanzapine and quetiapine. This makes it a popular choice for bipolar maintenance in patients concerned about metabolic side effects.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol on Lametec-100 DT?<\/h3>\n<p>Light, occasional alcohol is usually tolerated. Heavy or binge drinking adds CNS depression and lowers seizure threshold, increasing breakthrough seizure risk in epilepsy patients. Avoid alcohol entirely during the titration phase &mdash; it is harder to attribute symptoms (dizziness, ataxia, rash) correctly when alcohol is involved.<\/p>\n<h3 class=\"wp-block-heading\">Why did my prescriber order an ECG before starting Lametec-100 DT?<\/h3>\n<p>\u03a3\u03b5 <strong>March 2021 the FDA added a label warning<\/strong> about Brugada-like ECG changes and arrhythmia risk in patients with structural heart disease, conduction-system abnormalities or Brugada syndrome. A baseline ECG is reasonable in older adults with cardiac history; it is not required for healthy young patients without cardiac symptoms.<\/p>\n<h3 class=\"wp-block-heading\">How do I taper off Lametec-100 DT safely?<\/h3>\n<p>For epilepsy: <strong>taper over at least 2 weeks<\/strong>, ideally longer, under your neurologist&#8217;s supervision &mdash; sudden discontinuation can precipitate seizures and status epilepticus. For bipolar maintenance: tapering over 2&ndash;4 weeks reduces the risk of mood relapse but cannot fully prevent it; specialist input is recommended. Immediate discontinuation is only appropriate for serious adverse reactions (rash, DRESS, HLH).<\/p>\n<h3 class=\"wp-block-heading\">Where is Lametec-100 DT manufactured?<\/h3>\n<p>Lametec-100 DT is supplied by a <strong>\u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03b7 WHO-GMP \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae<\/strong> and is bioequivalent to originator-brand lamotrigine (Lamictal&reg;, GSK). Batch certificates of analysis are available on request.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2<\/h3>\n<p>\u0386\u03bb\u03bb\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03c3\u03b5 <strong>\u03a7\u03c1\u03cc\u03bd\u03b9\u03b5\u03c2 \u03a0\u03b1\u03b8\u03ae\u03c3\u03b5\u03b9\u03c2<\/strong> \u03c0\u03bf\u03c5 \u03bf\u03b9 \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2 \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03bf\u03c5\u03bd \u03b5\u03c0\u03af\u03c3\u03b7\u03c2:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/topaz\/\">Topaz<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/etibo\/\">Etibo<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/brufen\/\">Brufen<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/r-cin\/\">R-Cin<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Controls seizures<br \/>\n\u2705 Treats bipolar disorder<br \/>\n\u2705 Stabilizes mood swings<br \/>\n\u2705 Reduces manic episodes<br \/>\n\u2705 Minimizes depressive symptoms<\/p>\n<p>Lametec-100 DT contains Lamotrigine.<\/p>","protected":false},"featured_media":57998,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3468],"product_tag":[4398,4378],"class_list":{"0":"post-57997","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-neurological-conditions-and-epilepsy","9":"product_tag-lametec-100-dt","10":"product_tag-lamotrigine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/57997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=57997"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/57998"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=57997"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=57997"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=57997"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=57997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}